Go Pro

Telix Pharmaceuticals (TLX) Institutional Ownership

Telix Pharmaceuticals logo
$11.33 -1.09 (-8.78%)
As of 08/21/2026 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for Telix Pharmaceuticals (NASDAQ:TLX)

Number of
Institutional Buyers
(last 12 months)
14
Total
Institutional Inflows
(last 12 months)
$12.08M
Number of
Institutional Sellers
(last 12 months)
4
Total
Institutional Outflows
(last 12 months)
$1.76M
Get TLX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Telix Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

TLX Institutional Buying and Selling by Quarter

Telix Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/23/2026 XY Capital Ltd71,291$822K0.8%+468.0%0.021%
8/22/2026 Raiffeisen Bank International AG115,000$1.30M0.0%-11.5%0.034%
7/9/2026 Hennion & Walsh Asset Management Inc.150,138$1.73M0.0%N/A0.044%
5/19/2026 Bank of America Corp DE10,031$96K0.0%+523.8%0.003%
5/16/2026 Lazard Asset Management LLC289,917$2.78M0.0%+15.7%0.085%
5/12/2026 XY Capital Ltd12,552$120K0.1%N/A0.004%
4/27/2026 Private Advisor Group LLC174,415$1.67M0.0%+276.3%0.051%
2/18/2026 Vident Advisory LLC27,249$204K0.0%N/A0.008%
2/18/2026 XTX Topco Ltd11,820$89K0.0%N/A0.003%
2/18/2026 Quadrature Capital Ltd36,828$276K0.0%N/A0.011%
2/18/2026 OLD Mission Capital LLC14,799$111K0.0%N/A0.004%
2/18/2026 Millennium Management LLC19,733$148K0.0%-90.0%0.006%
2/17/2026 Lazard Asset Management LLC250,517$1.88M0.0%+118.6%0.074%
2/16/2026 Mariner LLC36,582$274K0.0%N/A0.011%
2/13/2026 Marshall Wace LLP46,658$349K0.0%-3.9%0.014%
2/12/2026 Jane Street Group LLC40,042$300K0.0%-45.1%0.012%
2/12/2026 Portland Investment Counsel Inc.266,200$2.06M0.6%+108.0%0.079%
1/1/2026 JPMorgan Chase & Co.25,355$243K0.0%N/A0.007%
11/17/2025 Millennium Management LLC196,741$1.88M0.0%N/A0.058%
11/14/2025 Lazard Asset Management LLC114,624$1.10M0.0%N/A0.034%
11/14/2025 Portland Investment Counsel Inc.128,000$1.23M0.3%N/A0.038%
11/13/2025 Private Advisor Group LLC42,112$403K0.0%+67.3%0.012%
11/7/2025 JPMorgan Chase & Co.25,355$243K0.0%N/A0.007%
11/6/2025 Rhumbline Advisers2,579$25K0.0%+117.3%0.001%
8/15/2025 IHT Wealth Management LLC13,240$213K0.0%N/A0.004%
8/14/2025 Jane Street Group LLC35,103$564K0.0%N/A0.010%
8/13/2025 Russell Investments Group Ltd.60,301$975K0.0%N/A0.018%
8/5/2025 Pier Capital LLC188,992$3.04M0.5%N/A0.056%
7/25/2025 Vanguard Personalized Indexing Management LLC18,475$297K0.0%N/A0.005%
7/24/2025 Blair William & Co. IL13,500$217K0.0%N/A0.004%
5/9/2025ABC Arbitrage SA26,939$451K0.1%N/A0.008%
5/5/2025Private Advisor Group LLC10,140$170K0.0%N/A0.003%


TLX Institutional Ownership - Frequently Asked Questions

During the previous two years, 23 institutional investors and hedge funds held shares of Telix Pharmaceuticals. The most heavily invested institutionals were Pier Capital LLC ($3.04M), Lazard Asset Management LLC ($2.78M), Portland Investment Counsel Inc. ($2.06M), Hennion & Walsh Asset Management Inc. ($1.73M), Private Advisor Group LLC ($1.67M), Raiffeisen Bank International AG ($1.30M), and Russell Investments Group Ltd. ($975K).Learn more on Telix Pharmaceuticals' institutional investors.

Of the 21 institutional investors that purchased Telix Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Lazard Asset Management LLC ($289.92K), Portland Investment Counsel Inc. ($266.20K), Millennium Management LLC ($196.74K), Pier Capital LLC ($188.99K), Private Advisor Group LLC ($155.16K), Hennion & Walsh Asset Management Inc. ($150.14K), and XY Capital Ltd ($71.29K).

Institutional investors have bought a total of 1,307,105 shares in the last 24 months. This purchase volume represents approximately $12.08M in transactions.

The following institutional investors have sold Telix Pharmaceuticals stock in the last 24 months: Millennium Management LLC ($177.01K), Jane Street Group LLC ($32.95K), Raiffeisen Bank International AG ($15K), and Marshall Wace LLP ($1.92K).

Institutional investors have sold a total of 226,873 shares in the last 24 months. This volume of shares sold represents approximately $1.76M in transactions.



Institutional ownership data for NASDAQ:TLX is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/23/2026. New 13F filings are added each quarter as they're published.
From Our Partners